Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming

Yousefi, Hassan; Khosla, Maninder; Lauterboeck, Lothar; Okpechi, Samuel C.; Worthylake, David; Garai, Jone; Zabaleta, Jovanny; Guidry, Jessie; Zarandi, Mohammad Amin; Wyczechowska, Dorota; Jayawickramarajah, Janarthanan; Yang, Qinglin; Kissil, Joseph; Alahari, Suresh K.

doi:10.1038/s41388-023-02608-7

Download PDF

Correction
Published: 09 February 2023

Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming

Hassan Yousefi¹,
Maninder Khosla¹,
Lothar Lauterboeck²,
Samuel C. Okpechi¹,
David Worthylake¹,
Jone Garai³,
Jovanny Zabaleta⁴,
Jessie Guidry⁵,
Mohammad Amin Zarandi⁶,
Dorota Wyczechowska³,
Janarthanan Jayawickramarajah⁶,
Qinglin Yang²,
Joseph Kissil⁷ &
…
Suresh K. Alahari ORCID: orcid.org/0000-0002-9651-6727¹

Oncogene volume 42, page 859 (2023)Cite this article

511 Accesses
Metrics details

Subjects

The Original Article was published on 15 October 2022

Correction to: Oncogene https://doi.org/10.1038/s41388-022-02497-2, published online 15 October 2022

The original online version of this article was revised: In Figure 3 F right panel (Dapi Eadh/GFP) was placed a wrong panel in the figure.

The corrected figure is given below.

The original article has been corrected.

Author information

Authors and Affiliations

Department of Biochemistry & Molecular Biology, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA
Hassan Yousefi, Maninder Khosla, Samuel C. Okpechi, David Worthylake & Suresh K. Alahari
Department of Pharmacology and Experimental Therapeutics, Cardiovascular Center of Excellence, Louisiana State University Health Science Center (LSUHSC) School of Medicine, New Orleans, LA, USA
Lothar Lauterboeck & Qinglin Yang
Stanley S. Scott Cancer Center, LSUHSC, New Orleans, LA, USA
Jone Garai & Dorota Wyczechowska
Department of Interdisciplinary Oncology and Stanley S. Scott Cancer Center, LSUHSC, New Orleans, LA, USA
Jovanny Zabaleta
Proteomics Core facility, Louisiana State University Health Science Center (LSUHSC), New Orleans, LA, USA
Jessie Guidry
Department of Chemistry, Tulane University, New Orleans, LA, USA
Mohammad Amin Zarandi & Janarthanan Jayawickramarajah
Department of Molecular Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA
Joseph Kissil

Authors

Hassan Yousefi
View author publications
You can also search for this author in PubMed Google Scholar
Maninder Khosla
View author publications
You can also search for this author in PubMed Google Scholar
Lothar Lauterboeck
View author publications
You can also search for this author in PubMed Google Scholar
Samuel C. Okpechi
View author publications
You can also search for this author in PubMed Google Scholar
David Worthylake
View author publications
You can also search for this author in PubMed Google Scholar
Jone Garai
View author publications
You can also search for this author in PubMed Google Scholar
Jovanny Zabaleta
View author publications
You can also search for this author in PubMed Google Scholar
Jessie Guidry
View author publications
You can also search for this author in PubMed Google Scholar
Mohammad Amin Zarandi
View author publications
You can also search for this author in PubMed Google Scholar
Dorota Wyczechowska
View author publications
You can also search for this author in PubMed Google Scholar
Janarthanan Jayawickramarajah
View author publications
You can also search for this author in PubMed Google Scholar
Qinglin Yang
View author publications
You can also search for this author in PubMed Google Scholar
Joseph Kissil
View author publications
You can also search for this author in PubMed Google Scholar
Suresh K. Alahari
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suresh K. Alahari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yousefi, H., Khosla, M., Lauterboeck, L. et al. Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming. Oncogene 42, 859 (2023). https://doi.org/10.1038/s41388-023-02608-7

Download citation

Published: 09 February 2023
Issue Date: 10 March 2023
DOI: https://doi.org/10.1038/s41388-023-02608-7

Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming

Subjects

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Search

Quick links

Subjects

Author information

Authors and Affiliations

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

Search

Quick links